Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
Stockholders Equity Over TimeStrong
Percentile Rank67
3Y CAGR-5.0%
Studio
Year-over-Year Change

Net worth of the company (assets minus liabilities)

3Y CAGR
-5.0%/yr
Annual compound
Percentile
P67
Within normal range
vs 3Y Ago
0.9x
Contraction
Streak
2 yr
Consecutive growthStrong
PeriodValueYoY Change
2025$233.06M+4.5%
2024$222.94M+24.4%
2023$179.25M-34.0%
2022$271.41M-21.9%
2021$347.51M+813.2%
2020$-48.73M-301.1%
2019$-12.15M-